Human Amniotic Mesenchymal Stem Cells Alleviate aGVHD after Allo-HSCT by Regulating Interactions between Gut Microbiota and Intestinal Immunity

Scientists defined the effects and underlying mechanisms of human amniotic membrane-derived MSCs regulating the gut microbiota and intestinal immunity in acute graft-versus-host disease (aGVHD).